The human rights issues raised by the conduct of maternal-fetal human immunodeficiency virus transmission trials in Africa are not unique to either acquired immunodeficiency syndrome or Africa, but public discussion of these trials presents on opportunity for the United States and other wealthy nations to take the rights and welfare of improverished populations seriously.
The central issue at stake when developed countries perform research on subjects in developing countries is exploitation.
The only way to prevent exploitation of a research population is to insist not only that informed consent be obtained but also that, should an intervention be proven beneficial, the intervention will be delivered to the improverished population.
Human rights are universal and cannot be compromised solely on the basis of beliefs or practices of any one country or group.
The challenge to the developed countries is to implement programs to improve the health of the people in developing countries both by improving public health infrastructure and by delivering effective drugs and vaccines to the people.
Mots-clés Pascal : Transmission mère enfant, SIDA, Virose, Infection, Prévention, Essai clinique, Exploitation population, Pays en développement, Afrique, Recherche appliquée, Ethique, Consentement éclairé, Homme, Femelle, Traitement, Immunopathologie, Immunodéficit, Zidovudine, Antiviral, Chimiothérapie, Droits fondamentaux
Mots-clés Pascal anglais : Mother to child transmission, AIDS, Viral disease, Infection, Prevention, Clinical trial, Population exploitation, Developing countries, Africa, Applied research, Ethics, Informed consent, Human, Female, Treatment, Immunopathology, Immune deficiency, Zidovudine, Antiviral, Chemotherapy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0224000
Code Inist : 002B30A09. Création : 11/09/1998.